FDA Approves First Twice-Yearly HIV Prevention Shot, Global Rollout Begins
The FDA approves Gilead’s twice-yearly HIV prevention shot, marking a milestone in global health with potential implications for Asia’s healthcare landscape.
GileadSciences
Read More